This biopharmaceutical uses human antibodies to develop treatments for cancers, inflammatory and infectious diseases.
Unfortunately they have filed for chapter 11 bankruptcy
This biopharmaceutical uses human antibodies to develop treatments for cancers, inflammatory and infectious diseases.
Unfortunately they have filed for chapter 11 bankruptcy